Anika Therapeutics Stock Price and Value Analysis

Should you buy Anika Therapeutics stock? (NasdaqGS:ANIK). Let's see how it does in our automated value investing analysis system.

  • This company pays no dividend.
  • AdvantagesDisadvantagesNeutral
    None.
    • This company is less known than others.
    • This company has wild ups and downs.
    • This company is making money at a modest rate.
    • This stock looks fairly priced.

    ANIK Free Cash Flow Trend

    Based on historical returns, we believe that Anika Therapeutics can grow its free cash at a rate of about 2%. That's positive!

    Free Cash Flow trendline for ANIK
    Free Cash Flow trendline for Anika Therapeutics

    Inside the ANIK Numbers

    ANIK Price
    (Anika Therapeutics stock price per share)
    $34.72
    [?] ANIK Fair Price
    (based on intrinsic value)
    $35.36
    [?] ANIK Safety Price (based on a variable margin of safety) $21.22
    [?] PE Ratio versus Sector 18% lower than other Healthcare stocks
    [?] PE Ratio versus Industry 71% lower than other Biotechnology stocks
    [?] Cash Yield 6.19%
    [?] Free Cash Flow Jitter 73%

    Is Anika Therapeutics Stock on Sale?

    We believe that Anika Therapeutics may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

    Anika Therapeutics looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

    Should You Buy ANIK Stock?

    Does Anika Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.